The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Turner Daniel K Iii since 2008.
The trader's CIK number is 1280249.
At the time of the last reporting, Turner Daniel K Iii was the Director of Orexigen Therapeutics, Inc.. (stock ticker symbol OREXQ).
Also see all insider trading activities at Orexigen Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2011 | TSPT | 0 | $0 | 130,000 | $1,061,840 | 0 | $0 |
2009 | TSPT | 0 | $0 | 76,054 | $990,017 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2010 | SOMX | 0 | $0 | 1,500,000 | $9,573,000 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2011 | OREX | 57,204 | $82,945 | 0 | $0 | 0 | $0 |
2010 | OREX | 0 | $0 | 700,000 | $428,529 | 0 | $0 |
2009 | OREX | 0 | $0 | 500,000 | $4,496,756 | 0 | $0 |
2008 | OREX | 300,000 | $1,038,300 | 0 | $0 | 0 | $0 |
1. Paratek Pharmaceuticals, Inc. (TSPT)
2. Somaxon Pharmaceuticals, Inc. (SOMX)
3. Orexigen Therapeutics, Inc. (OREX)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2011-03-29 | TSPT | Sale | 130,000 | 8.17 | 1,061,840 |
2009-09-11 | TSPT | Sale | 10,450 | 12.59 | 131,544 |
2009-09-09 | TSPT | Sale | 35,030 | 13.16 | 460,889 |
2009-09-10 | TSPT | Sale | 30,574 | 13.00 | 397,584 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2010-03-18 | SOMX | Sale | 1,500,000 | 6.38 | 9,573,000 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2011-12-22 | OREX | Buy | 57,204 | 1.45 | 82,945 |
2010-12-22 | OREX | Sale | 51,943 | 8.25 | 428,529 |
2010-12-23 | OREX | Sale | 48,057 | .00 | 0 |
2010-12-10 | OREX | Sale | 333,635 | .00 | 0 |
2010-12-13 | OREX | Sale | 266,365 | .00 | 0 |
2009-12-17 | OREX | Sale | 100,000 | 7.55 | 755,000 |
2009-09-22 | OREX | Sale | 100,000 | 10.22 | 1,021,800 |
2009-09-17 | OREX | Sale | 100,000 | 9.28 | 927,999 |
2009-09-16 | OREX | Sale | 40,904 | 8.93 | 365,068 |
2009-09-14 | OREX | Sale | 23,395 | 9.00 | 210,601 |
2009-09-15 | OREX | Sale | 135,701 | 8.96 | 1,216,288 |
2008-12-05 | OREX | Buy | 300,000 | 3.46 | 1,038,300 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Turner Daniel K Iii (Director of Orexigen Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.